• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconMonsanto Roundup

Monsanto Roundup

Bayer shares plunge 10% as ongoing U.S. lawsuits trigger cash-raising plans
Finance
Bayer shares plunge 10% as ongoing U.S. lawsuits trigger cash-raising plans
By AFPMarch 7, 2025
Photo of Bill Anderson
Success
A year after Bayer got rid of bosses and asked staff to self-organize, its CEO says attrition has fallen
By Ryan HoggDecember 24, 2024
Bill Anderson, chief executive officer of Bayer AG, at the Ukraine Recovery Conference in Berlin, Germany, on Wednesday, June 12, 2024. The June 11-12 conference in the German capital is aimed at pooling efforts from Ukraine's allies for postwar reconstruction. Photographer: Krisztian Bocsi/Bloomberg via Getty Images
Finance
German giant Bayer back in the red as agrochemicals slump and Monsanto lawsuits mount
By AFPAugust 6, 2024
Bottles of Roundup on a shelf
Finance
Judge slashes Bayer’s $1.5 billion Roundup verdict by more than 60% after Supreme Court decision on limiting punishments
By Jef Feely and BloombergApril 5, 2024
Photo of Bill Anderson
Health
Bayer CEO compares the state of troubled pharma group to the time he fractured his leg skateboarding: ‘We’re badly broken in 4 places’
By Ryan HoggMarch 6, 2024
Roundup
Health
57-year-old man wins $332 million verdict against Monsanto on claim that Roundup weedkiller gave him incurable cancer
By The Associated PressNovember 3, 2023
Bayer hit with $332 million judgement in trial of man who blames his cancer on decades using Monsanto’s Roundup weedkiller
Finance
Bayer hit with $332 million judgement in trial of man who blames his cancer on decades using Monsanto’s Roundup weedkiller
By The Associated PressNovember 3, 2023
Roundup weed killer that is the subject of thousands of lawsuits in the US, is pictured on sale in Los Angeles, California on September 1, 2019.
Finance
Bayer could settle the Roundup cancer litigation, but the drama is far from over
By David MeyerJune 25, 2020
Bayer agrees to pay $12 billion in legal settlements, in effort to put Roundup scandal behind it
Bayer agrees to pay $12 billion in legal settlements, in effort to put Roundup scandal behind it
By Jef Feeley, Tim Loh and BloombergJune 25, 2020
Roundup weedkiller cancer claims soar as coronavirus outbreak complicates settlement talks
Finance
Roundup weedkiller cancer claims soar as coronavirus outbreak complicates settlement talks
By Tim Loh and BloombergApril 27, 2020
The CEO of German chemicals giant Bayer, Werner Baumann, speaks during the company's annual news conference in Leverkusen, western Germany, on February 27, 2020. - German chemical and pharmaceutical giant Bayer reported surging profits for 2019 after its buying US seeds and pesticides maker Monsanto, but remained entangled in a massive wave of lawsuits over a flagship weedkiller. (Photo by Ina FASSBENDER / AFP) (Photo by INA FASSBENDER/AFP via Getty Images)
Finance
Bayer says Roundup legal fiasco may force it to sell assets or borrow on bad terms
By Tim Loh and BloombergFebruary 27, 2020
A sign for Monsanto Co. Xtendimax herbicide, a dicamba product developed to combat "superweeds" resistant to RoundUp glyphosate herbicide, hangs in the Monsanto booth during the Farm Progress Show in Decatur, Illinois, U.S., on Tuesday, Aug. 29, 2017. The show, sponsored by Farm Progress Co. and owned by Penton Media, is billed as the largest outdoor farm show in the U.S. Photographer: Daniel Acker/Bloomberg via Getty Images
Environment
Bayer is facing a new wave of herbicide lawsuits—and this time it’s not over Monsanto’s Roundup
By Jef Feeley, Tim Bross and BloombergFebruary 17, 2020
Roundup weed killer is the subject of thousands of lawsuits in the U.S. It has been blamed for ailments including non-Hodgkin’s lymphoma, which can take years to diagnose.
Health
Bayer may pay $10 billion to settle Roundup cancer cases from its Monsanto deal
By Jef Feeley, Tim Loh and BloombergJanuary 24, 2020
Roundup weed killer that is the subject of thousands of lawsuits in the US, is pictured on sale in Los Angeles, California on September 1, 2019. (Photo by Mark RALSTON / AFP) (Photo credit should read MARK RALSTON/AFP/Getty Images)
Finance
As Roundup Lawsuits Pile Up by the Thousands, Bayer Remains Defiant
By Adrian CroftOctober 30, 2019
Roundup weed killer that is the subject of thousands of lawsuits in the US, is pictured on sale in Los Angeles, California on September 1, 2019. (Photo by Mark RALSTON / AFP) (Photo credit should read MARK RALSTON/AFP/Getty Images)
Health
Bayer’s $30 Billion Roundup Crisis Heats Up as It Braces for a ‘Significant Surge’ of New Lawsuits
By Tim Loh and BloombergOctober 16, 2019
1
  • 1
  • 2
  • 3
3
Most Popular
Big Tech
As Big Tech showers employees with perks to win the talent war, Nvidia built a nearly $5 trillion company by making people pay for their own lunchplaceholder alt text
By Marco Quiroz-GutierrezJuly 1, 2026
Success
MacKenzie Scott alone accounted for one-third of America's $19.2 billion in megagifts last yearplaceholder alt text
By Sydney LakeJune 25, 2026
Newsletters
The Supreme Court's birthright citizenship ruling hands the U.S. economy a $7.7 trillion winplaceholder alt text
By Diane BradyJuly 1, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.